StockData
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31

MEDIFAST INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$12.03+0.15 (+1.26%)

Close on Oct 19, 2026

Market cap
$133.95M
P/E (TTM)
–
Dividend yield
0.00%

MEDIFAST INC revenue by segment

By business segment

RevenueTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q4 17TTM Q3 17TTM Q2 17TTM Q1 17TTM Q4 16% of revenueYoY
Optavia Segment$316.93M$346.10M$385.79M$429.70M$480.45M$543.45M$602.46M–––––100.0%-34.0%
Medifast Direct [Member]–––––––$31.90M$32.10M$32.42M$33.17M$35.14M––
Take Shape For Life [Member]––––––––––$223.68M$222.40M––
MWCC [Member]–––––––$12.19M$13.22M$14.15M$14.88M$15.67M––
Medifast Wholesale [Member]–––––––$931.00K$961.00K$1.01M$1.08M$1.32M––
Optavia [Member]–––––––$256.54M–––$222.40M––

By product or service

By region

From the segment and revenue-disaggregation notes of Medifast's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.